Intravitreal and posterior subtenon triamcinolone acetonide for severe acute posterior multifocal placoid pigment epitheliopathy

Arq Bras Oftalmol. 2019 May-Jun;82(3):233-235. doi: 10.5935/0004-2749.20190045. Epub 2019 Mar 25.

Abstract

A 21-year-old man presented with visual acuity of 20/200 in both eyes. The fundus picture, fluorescein angiography, and optical coherence tomography revealed severe bilateral acute posterior multifocal placoid pigment epitheliopathy and serous macular detachments. We treated the patient with triamcinolone acetonide, an intravitreal injection (4 mg/0.1 mL) in one eye and a posterior subtenon injection (40 mg/1 mL) in the other eye. Within 2 weeks the visual acuity was 20/80 in both eyes. At the 8-week follow-up visit his vision was 20/63 bilaterally. One year later the vision remained 20/63 in both eyes. In this patient, the triamcinolone acetonide injections, whether administered intravitreally or via the posterior subtenon route, achieved similar anatomic and functional recovery results.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Fluorescein Angiography
  • Humans
  • Intravitreal Injections / methods*
  • Male
  • Tenon Capsule*
  • Time Factors
  • Tomography, Optical Coherence / methods
  • Treatment Outcome
  • Triamcinolone Acetonide / administration & dosage*
  • Visual Acuity
  • White Dot Syndromes / diagnostic imaging
  • White Dot Syndromes / drug therapy*
  • White Dot Syndromes / pathology
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Triamcinolone Acetonide